Induction treatment with rabbit antithymocyte globulin versus basiliximab in renal transplant recipients with planned early steroid withdrawal.

Study Objective: To compare the safety and efficacy of rabbit antithymocyte globulin (r-ATG) with basiliximab in renal transplant recipients for whom an early steroid withdrawal (ESW) regimen was planned.

Design: Single-center, retrospective, cohort study.

Setting: Tertiary care medical center, including inpatient hospital stays and outpatient nephrology clinics.